FDA Grants Breakthrough Device Designation To VR Mental Illness Treatment

A British startup that uses virtual reality to help deliver cognitive behavior therapy has been granted a Breakthrough Device designation by the Food and Drug Administration for its treatment for schizophrenia and other serious mental illnesses, a process that will help expedite its ultimate approval if clinical trials pan out.